Open AccessQuality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter
Author(s) -
Dennis A. Revicki,
Graeme Moyle,
HansJürgen Stellbrink,
Chris Barker
Publication year - 1999
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/00002030-199905070-00016
Subject(s) - zidovudine , zalcitabine , saquinavir , medicine , regimen , viral load , virology , human immunodeficiency virus (hiv) , viral disease , antiretroviral therapy
This double-blind study evaluated treatment with zalcitabine-zidovudine, saquinavir-zidovudine, or saquinavir-zalcitabine-zidovudine on the health-related quality of life of HIV-infected adults with CD4 cell counts between 50 and 350 cells/mm3.